JIR
CSII

James Investment Research’s Cardiovascular Systems, Inc. CSII Stock Holding History

James Investment Research’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,575
Closed -$51K – 821
2017
Q2 		$51K Hold
1,575
– – ﹤0.01% 602
2017
Q1 		$45K Buy
+1,575
New +$41.8K ﹤0.01% 546

Other funds holding CSII

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Frontier Capital Management
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

James Investment Research's CSII Position: Q3 2017 in Review

James Investment Research sold out of Cardiovascular Systems, Inc. (CSII) in Q3 2017, closing a stake of 1,575 shares — an estimated $51K sold.

James Investment Research first reported a position in CSII in Q1 2017 and held it in 2 quarters. The position peaked at $51K in Q2 2017. 142 funds tracked by Wall St. Rank hold CSII as of Q3 2017.

  • James Investment Research reported no remaining Cardiovascular Systems, Inc. position as of Q3 2017 after selling out during the quarter.
  • James Investment Research sold 1,575 Cardiovascular Systems, Inc. shares in Q3 2017, an estimated $51K.
  • James Investment Research first reported a position in Cardiovascular Systems, Inc. in Q1 2017 and held it in 2 quarters.
  • James Investment Research's Cardiovascular Systems, Inc. position peaked at $51K in Q2 2017.
  • 142 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q3 2017.

Based on James Investment Research's 13F filing for Q3 2017, filed 13 Oct 2017.